These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
428 related items for PubMed ID: 18028894
1. Matrix metalloproteinase-1, -3, and -9 gene polymorphisms and the risk of idiopathic dilated cardiomyopathy in a Chinese Han population. Tang LJ, Chen XF, Zhu M, Jiang JJ, Lu XB, Du YX, Wang B, Fang CF, Xue YS, Shen WF. Clin Biochem; 2007 Dec; 40(18):1427-30. PubMed ID: 18028894 [Abstract] [Full Text] [Related]
9. The association of MMP-1, -3 and -9 genotypes with the prognosis of HCV-related hepatocellular carcinoma patients. Okamoto K, Mandai M, Mimura K, Murawaki Y, Yuasa I. Res Commun Mol Pathol Pharmacol; 2005 Dec; 117-118():77-89. PubMed ID: 18426080 [Abstract] [Full Text] [Related]
10. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer]. Fang SM, Jin X, Li Y, Wang R, Guo W, Wang N, Zhang JH. Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531 [Abstract] [Full Text] [Related]
11. No association between the polymorphisms in matrix metalloproteinase-1 and matrix metalloproteinase-3 promoter regions and colorectal cancer in Chinese. Xu E, Lai M, Lŭ B, Xing X, Huang Q. Dis Colon Rectum; 2006 Sep; 49(9):1439-44. PubMed ID: 16937230 [Abstract] [Full Text] [Related]
15. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. Ghilardi G, Biondi ML, Caputo M, Leviti S, DeMonti M, Guagnellini E, Scorza R. Clin Cancer Res; 2002 Dec; 8(12):3820-3. PubMed ID: 12473595 [Abstract] [Full Text] [Related]
17. Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer. Woo M, Park K, Nam J, Kim JC. J Gastroenterol Hepatol; 2007 Jul; 22(7):1064-70. PubMed ID: 17608852 [Abstract] [Full Text] [Related]
18. Matrix metalloproteinase-1 and -9 promoter polymorphisms are not associated with an increased risk of uterine leiomyomas in a Japanese population. Takemura N, Yoshida S, Kennedy S, Deguchi M, Ohara N, Maruo T. J Soc Gynecol Investig; 2006 Apr; 13(3):232-6. PubMed ID: 16638593 [Abstract] [Full Text] [Related]
20. Association of matrix metalloproteinase (MMP)-1 promoter polymorphism with head and neck squamous cell carcinoma. Hashimoto T, Uchida K, Okayama N, Imate Y, Suehiro Y, Hamanaka Y, Ueyama Y, Shinozaki F, Yamashita H, Hinoda Y. Cancer Lett; 2004 Jul 28; 211(1):19-24. PubMed ID: 15194213 [Abstract] [Full Text] [Related] Page: [Next] [New Search]